User login
Article Type
Changed
Fri, 01/04/2019 - 11:11
Display Headline
Significant response to lacosamide in a patient with severe chemotherapy-induced peripheral neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting toxicity of potentially curative cancer therapy regimens. Cisplatin is the class of chemotherapy agent that has a broad spectrum of activity against several solid tumors, but it induces sensory neuropathy of upper and lower extremities. Cisplatin-induced peripheral neuropathy is usually in a “gloves and socks” distribution that can persist for months or years after completion of chemotherapy treatment. If the pain is severe, it affects the patient’s long-term quality of life and can potentially result in chemotherapy dose reduction or treatment discontinuation.
Click on the PDF icon at the top of this introduction to read the full article.
Article PDF
Issue
The Journal of Community and Supportive Oncology - 13(5)
Page Number
202-204
Legacy Keywords
peripheral neuropathy, chemotherapy-induced peripheral neuropathy, CIPN, lacosamide, cisplatin, MVAC, methotrexate, vincristine, adriamycin, and cisplatin,
Sections
Article PDF
Article PDF
Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting toxicity of potentially curative cancer therapy regimens. Cisplatin is the class of chemotherapy agent that has a broad spectrum of activity against several solid tumors, but it induces sensory neuropathy of upper and lower extremities. Cisplatin-induced peripheral neuropathy is usually in a “gloves and socks” distribution that can persist for months or years after completion of chemotherapy treatment. If the pain is severe, it affects the patient’s long-term quality of life and can potentially result in chemotherapy dose reduction or treatment discontinuation.
Click on the PDF icon at the top of this introduction to read the full article.
Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting toxicity of potentially curative cancer therapy regimens. Cisplatin is the class of chemotherapy agent that has a broad spectrum of activity against several solid tumors, but it induces sensory neuropathy of upper and lower extremities. Cisplatin-induced peripheral neuropathy is usually in a “gloves and socks” distribution that can persist for months or years after completion of chemotherapy treatment. If the pain is severe, it affects the patient’s long-term quality of life and can potentially result in chemotherapy dose reduction or treatment discontinuation.
Click on the PDF icon at the top of this introduction to read the full article.
Issue
The Journal of Community and Supportive Oncology - 13(5)
Issue
The Journal of Community and Supportive Oncology - 13(5)
Page Number
202-204
Page Number
202-204
Article Type
Display Headline
Significant response to lacosamide in a patient with severe chemotherapy-induced peripheral neuropathy
Display Headline
Significant response to lacosamide in a patient with severe chemotherapy-induced peripheral neuropathy
Legacy Keywords
peripheral neuropathy, chemotherapy-induced peripheral neuropathy, CIPN, lacosamide, cisplatin, MVAC, methotrexate, vincristine, adriamycin, and cisplatin,
Legacy Keywords
peripheral neuropathy, chemotherapy-induced peripheral neuropathy, CIPN, lacosamide, cisplatin, MVAC, methotrexate, vincristine, adriamycin, and cisplatin,
Sections
Citation Override
JCSO 2015;13:202-204
Disallow All Ads
Alternative CME
Article PDF Media
Document